OncSCE

MRCP(UK) Specialty Certificate · Medical Oncology

Revise for the Oncology SCE one vignette at a time.

Single-best-answer questions written to the SCE blueprint. Every answer comes with a short, referenced explanation that covers why the distractors are wrong, too.

Questions
63
Topics
16
Updated
18 November 2026

Question of the day

Sunday 22 November · Upper GI and HPB Cancer

A 64-year-old man with hepatitis C-related cirrhosis (Child-Pugh A) had an unresectable hepatocellular carcinoma with portal vein invasion. His performance status was 0 and atezolizumab with bevacizumab was planned.

Which of the following is most important before starting treatment?

Answer options

Choose one answer.

How it works

Built for short, focused revision sessions.

  1. 01

    Pick a session

    Choose a topic or mix everything, set the difficulty, and decide how many questions to take. Turn on unseen-only to keep moving through the bank.

  2. 02

    Answer the vignette

    Each question is a clinical scenario with five options and one best answer, in the same format as the SCE. Use keys A to E and Enter to move quickly.

  3. 03

    Learn from the explanation

    See the answer straight away with a short explanation and a guideline or trial reference, then track accuracy and coverage by topic.

Topic index

Mapped to the SCE curriculum.

New questions are added every week. Counts update as the bank grows.

  1. 01

    Acute Oncology and Emergencies

    Neutropenic sepsis, MSCC, SVCO, hypercalcaemia, tumour lysis and treatment toxicity.

    5 questions
  2. 02

    Breast Cancer

    Early and advanced disease, endocrine therapy, HER2-directed treatment, CDK4/6 inhibitors and hereditary risk.

    4 questions
  3. 03

    Cancer Biology and Genetics

    Hallmarks of cancer, oncogenes, DNA repair, inherited cancer syndromes and genomic testing.

    3 questions
  4. 04

    Clinical Trials, Statistics and Evidence

    Trial design, endpoints, survival analysis, bias and critical appraisal.

    3 questions
  5. 05

    CNS Tumours

    Gliomas, molecular classification, brain metastases and primary CNS lymphoma.

    2 questions
  6. 06

    Colorectal and Anal Cancer

    Adjuvant therapy, metastatic sequencing, RAS/BRAF/MSI biomarkers and anal SCC.

    6 questions
  7. 07

    Gynaecological Cancer

    Ovarian, endometrial, cervical and vulval cancers, PARP inhibition and gestational trophoblastic disease.

    3 questions
  8. 08

    Head and Neck and Thyroid Cancer

    HPV-related and unrelated SCC, nasopharyngeal cancer, salivary and thyroid malignancy.

    4 questions
  9. 09

    Immunotherapy and Immune-related Adverse Events

    Checkpoint inhibitor mechanisms, response patterns and management of irAEs.

    3 questions
  10. 10

    Lung and Thoracic Cancer

    NSCLC driver mutations, immunotherapy, SCLC, mesothelioma and thymic tumours.

    5 questions
  11. 11

    Melanoma and Skin Cancer

    Adjuvant and metastatic melanoma, BRAF/MEK inhibition, Merkel cell and cutaneous SCC.

    3 questions
  12. 12

    Sarcoma and Rare Tumours

    Soft tissue and bone sarcoma, neuroendocrine tumours and cancer of unknown primary.

    3 questions
  13. 13

    Supportive and Palliative Care

    Symptom control, antiemetics, VTE, pain, end-of-life care and survivorship.

    4 questions
  14. 14

    Systemic Therapy Pharmacology and Toxicity

    Mechanisms, pharmacokinetics, dosing and toxicity of chemotherapy and targeted agents.

    5 questions
  15. 15

    Upper GI and HPB Cancer

    Oesophagogastric, pancreatic, hepatocellular and biliary tract cancers, and GIST.

    5 questions
  16. 16

    Urological and Germ Cell Tumours

    Prostate, renal, bladder, penile and testicular germ cell tumours.

    5 questions

Membership

Start free. Upgrade when you are ready.

Prices include VAT where applicable.

Free

£0forever

Try 20 questions with full explanations. No card needed.

Membership

Best value

£30every 3 months

Renews every three months. Cancel any time and keep access until the period ends.

One month

£15one-off, 1 month

A single payment for one month of full access. Does not renew.

  • Every question in the bank, across all 16 topics
  • Referenced explanations for every answer
  • Topic, difficulty and unseen-only filters
  • Full progress tracking and attempt history

What's new

From the editor.

  • OncSCE opens

    The first questions are live across acute oncology, immunotherapy, thoracic, colorectal, germ cell, pharmacology and trial statistics. More are added every week.

Questions

Frequently asked.

What is the Medical Oncology SCE?

The Specialty Certificate Examination in Medical Oncology is a computer-based exam set by the MRCP(UK) and the Association of Cancer Physicians. It is a required part of specialty training for UK oncology registrars and uses single-best-answer questions.

How are the questions written?

Each question is a clinical vignette with five options and one best answer, matching the SCE format. Explanations are short, cover the key distractors, and cite a guideline or landmark trial rather than a website. Where UK practice differs, answers follow NICE and UK guidance.

What do I get for free?

A free account gives you 20 questions with full explanations and progress tracking. Revisiting a question you have already answered never uses up your allowance.

How does membership work?

Membership is £30 every three months and renews automatically until you cancel. If you prefer not to subscribe, a one-off payment of £15 gives one month of full access and does not renew.

Can I cancel at any time?

Yes. You can cancel from your settings and keep full access until the end of the period you have paid for.

Is OncSCE affiliated with the Royal College of Physicians?

No. OncSCE is an independent revision resource and is not affiliated with or endorsed by the Royal Colleges of Physicians or the MRCP(UK).

Your first 20 questions are on us.

Create a free account